WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 482
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 622

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 52'797  52'351  51'931  51'540  51'174  48'453  42'123  34'475 
Births 922  927  931  935  939  1'009  1'129  1'245 
Surviving infants 877  881  884  887  890  947  1'043  1'126 
Pop. less than 5 years 4'434  4'440  4'416  4'415  4'407  4'856  5'318  5'292 
Pop. less than 15 years 13'367  13'461  13'539  13'636  13'728  14'894  15'868  14'170 
Female 15-49 years 15'463  15'348  15'240  15'134  15'030  13'880  10'704  8'133 

Number of reported case

(Click for retrospective incidence data for Myanmar)
Diphtheria 19  19  17  181  830 
Japanese encephalitis 14  20  18 
Measles 2'175  2'046  190  329  333  845  7'900  21'457 
Mumps
Pertussis 55  7'882  26'878 
Polio* 44  47  244 
Rubella 21  103  11  13 
Rubella (CRS)
Tetanus (neonatal) 29  32  19  34  25  41  27  124 
Tetanus (total) 75  178  96  229  147  312  769  2'423 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Myanmar)
Vaccine year result method % card seen                                                
BCG 2008  98  MICS   96.0  87  93  93  93  88  88  67 
DTP1 2008  98  MICS   96.0  89  88  93  93  88  87 
DTP3 2008  98  MICS   96.0  85  86  90  90  85  82  69 
HepB_BD         
HepB3 2008  98  MICS   96.0  38  90  90  84 
Hib3         
JapEnc         
MCV 2008  98  MICS   96.0  84  88  88  87  82  84  68 
MCV2          80  75  65  57 
PCV1         
PCV3         
Pol3 2008  98  MICS   96.0  87  90  90  90  85  86  69 
Rota1         
Rota_last         
Rubella1         
TT2plus 1999  78  MICS   51.6  85  87  86  94  82  81  56 
PAB         
VAD1          95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Myanmar)
BCG 87  93  93  93  88  88  95 
DTP1 89  88  93  93  88  87  96  22 
DTP3 85  86  90  90  85  82  88 
HepB3 38  38  90  90  84 
Hib3
MCV 84  88  88  87  82  84  68 
PAB 93  93  93  93  93  79  62 
PCV3
Pol3 87  90  90  90  85  86  88 
Rota_last

Number of districts in the country 330  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
96 
   
/
|
|
\
Greater or equal to 90% 41
From 80 to 89% 24
From 50 to 79% 21
Less than 50% 10
Proportion of districts
not reporting DTP3 coverage
4
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 weeks; Yes
DTwPHibHepB 2, 4, 6 months; From November 2012
Measles 9, 18 months; Yes
OPV 6, 10, 14 weeks; Yes at 2, 4, 6 months from November 2012
TT 1st contact pregnancy; +4 weeks; Yes
VitaminA 6-59, 13-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2012-2016  2007-2011  2007-2011  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 324  330  319  300  325  325   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 330  330  325  325  325  325  324 
Nº districts with DTP3 coverage >=80% number 214  252  284  289  225  249  202 
% of districts with DTP3 coverage >=80% From 0 to 100% 65  76  87  89  69  77  62 
Nº districts with measles (MCV1) coverage >=95% number 74  81  81  62  56     
% of districts with MCV1 coverage >=95% From 0 to 100% 22  25  25  19  17     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 56             

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.